| [1] |
Pollheimer MJ, Fickert P, Stieger B. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis. Mol Aspects Med, 2014, 37: 35-56.
|
| [2] |
Ellinghaus D, Jostins L, Spain SL, et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet, 2016，48：510-518.
|
| [3] |
Goyette P, Boucher G, Mallon D, et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1 01: 03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet, 2015, 47: 172-179.
|
| [4] |
Vries EM, Wang J, Leeflang MM, et al. Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value. Liver Int, 2016, 36: 1867-1875.
|
| [5] |
Nevens F, Andreone P, Mazzella G, et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. New Engl J Med, 2016, 375: 631-643.
|
